This is a StreetInsider.com Premium Only Page

(LYRA) –

Apr 19, 2024 04:21 PM Form PRE 14A Lyra Therapeutics, Inc. For: Jun 13

Apr 19, 2024 04:17 PM Form 8-K Lyra Therapeutics, Inc. For: Apr 15

Apr 2, 2024 06:06 AM Form EFFECT Lyra Therapeutics, Inc.

Mar 22, 2024 07:42 AM Form S-8 Lyra Therapeutics, Inc.

Mar 22, 2024 07:40 AM Lyra Therapeutics (LYRA) Files $300M Mixed Shelf

Mar 22, 2024 07:39 AM Form S-3 Lyra Therapeutics, Inc.

Mar 22, 2024 06:59 AM Form 10-K Lyra Therapeutics, Inc. For: Dec 31

Mar 21, 2024 04:13 PM Form 8-K Lyra Therapeutics, Inc. For: Mar 21

Mar 21, 2024 04:01 PM Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Mar 20, 2024 07:22 PM Form 4 Lyra Therapeutics, Inc. For: Mar 18 Filed by: Waksal Harlan

Mar 20, 2024 07:21 PM Form 4 Lyra Therapeutics, Inc. For: Mar 18 Filed by: Palasis Maria

Mar 1, 2024 04:30 PM Form 8-K Lyra Therapeutics, Inc. For: Feb 26

Mar 1, 2024 04:01 PM Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Feb 15, 2024 09:19 AM Form SC 13G/A Lyra Therapeutics, Inc. Filed by: PURA VIDA INVESTMENTS, LLC

Feb 14, 2024 08:36 PM Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Venrock Healthcare Capital Partners II, L.P.

Feb 14, 2024 06:19 PM Form SC 13G/A Lyra Therapeutics, Inc. Filed by: CITADEL ADVISORS LLC

Feb 14, 2024 04:52 PM Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Nantahala Capital Management, LLC

Feb 14, 2024 04:30 PM Form SC 13D/A Lyra Therapeutics, Inc. Filed by: PERCEPTIVE ADVISORS LLC

Feb 14, 2024 04:18 PM Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.

Feb 13, 2024 04:35 PM Form SC 13G Lyra Therapeutics, Inc. Filed by: Vestal Point Capital, LP

Feb 1, 2024 04:16 PM Form 4 Lyra Therapeutics, Inc. For: Jan 30 Filed by: Bishop John E

Feb 1, 2024 04:16 PM Form 4 Lyra Therapeutics, Inc. For: Jan 30 Filed by: Nieman Richard

Feb 1, 2024 04:15 PM Form 4 Lyra Therapeutics, Inc. For: Jan 30 Filed by: Cavalier Jason

Jan 8, 2024 06:14 AM Form 8-K Lyra Therapeutics, Inc. For: Jan 08

Dec 28, 2023 06:41 AM Form 8-K Lyra Therapeutics, Inc. For: Dec 21

Dec 18, 2023 04:16 PM Form 8-K Lyra Therapeutics, Inc. For: Dec 14

Nov 16, 2023 05:04 PM Point72 Asset Management, L.P. Shows 5.4% Stake in Lyra Therapeutics (LYRA) - 13G

Nov 16, 2023 05:01 PM Form SC 13G Lyra Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.

Nov 13, 2023 05:30 PM Form 4 Lyra Therapeutics, Inc. For: Nov 10 Filed by: Waksal Harlan

Nov 7, 2023 04:49 PM Lyra Therapeutics (LYRA) Tops Q3 EPS by 5c

Nov 7, 2023 04:23 PM Form 10-Q Lyra Therapeutics, Inc. For: Sep 30

Nov 7, 2023 04:10 PM Form 8-K Lyra Therapeutics, Inc. For: Nov 07

Nov 7, 2023 04:01 PM Lyra Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Nov 7, 2023 07:00 AM Lyra Therapeutics to Participate in Upcoming Investor Conferences

Oct 16, 2023 07:00 AM Lyra Therapeutics Announces Appointment of Ronan O’Brien as Chief Legal Officer

Oct 6, 2023 06:44 AM BTIG Assumes Lyra Therapeutics (LYRA) at Buy

Sep 13, 2023 06:32 AM Lyra Therapeutics (LYRA) PT Raised to $15 at BofA Securities

Sep 12, 2023 04:02 PM Form 8-K Lyra Therapeutics, Inc. For: Sep 12

Sep 12, 2023 07:37 AM Cantor on Lyra Therapeutics (LYRA):'Better-Than-Expected BEACON Results Expand Opportunity for LYRA's CRS Platform'

Sep 12, 2023 07:32 AM Lyra Therapeutics (LYRA) Resumes Trading, Up 28% Following Positive Results

Sep 12, 2023 07:00 AM Lyra Therapeutics (LYRA) Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220

Sep 12, 2023 07:00 AM Lyra Therapeutics Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220 for the Treatment of Chronic Rhinosinusitis (CRS) in Patients with Prior Ethmoid Sinus Surgery

Sep 12, 2023 06:56 AM Lyra Therapeutics (LYRA) Halted, News Pending

Sep 6, 2023 08:00 AM Lyra Therapeutics to Participate in Upcoming Investor Conferences

Sep 1, 2023 04:03 PM Form 8-K Lyra Therapeutics, Inc. For: Sep 01

Sep 1, 2023 04:02 PM Form 424B5 Lyra Therapeutics, Inc.

Aug 31, 2023 06:09 AM H.C. Wainwright Starts Lyra Therapeutics (LYRA) at Buy

Aug 29, 2023 07:00 AM Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN I Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis

Aug 25, 2023 04:16 PM Form SC 13G Lyra Therapeutics, Inc. Filed by: Samsara BioCapital, L.P.

Aug 9, 2023 09:24 AM Lyra Therapeutics (LYRA) PT Lowered to $13 at BofA Securities